These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

970 related articles for article (PubMed ID: 22831471)

  • 21. Sports drug testing--an analyst's perspective.
    Trout GJ; Kazlauskas R
    Chem Soc Rev; 2004 Jan; 33(1):1-13. PubMed ID: 14737504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of therapeutic use exemptions at the Olympic Games and association with medals: an analysis of data from 2010 to 2018.
    Vernec A; Healy D
    Br J Sports Med; 2020 Aug; 54(15):920-924. PubMed ID: 32376674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent developments in drug abuse and doping control in sport.
    Radford PF
    J R Coll Surg Edinb; 1990 Dec; 35(6 Suppl):S2-6. PubMed ID: 2079694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Annual banned-substance review: analytical approaches in human sports drug testing.
    Thevis M; Kuuranne T; Geyer H; Schänzer W
    Drug Test Anal; 2013 Jan; 5(1):1-19. PubMed ID: 23229872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measurement uncertainty in anti-doping quantitative analysis for prohibited threshold substances.
    Barroso O; Miller J; Squirrell A; Westwood S
    Bioanalysis; 2012 Jul; 4(13):1653-65. PubMed ID: 22831481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Doping control analysis at the Rio 2016 Olympic and Paralympic Games.
    Pereira HMG; Sardela VF; Padilha MC; Mirotti L; Casilli A; de Oliveira FA; de Albuquerque Cavalcanti G; Rodrigues LML; de Araujo ALD; Levy RS; Teixeira PAC; de Oliveira FAG; Duarte ACG; Carneiro ACD; Evaristo JAM; Dos Santos GRC; da Costa GCV; de Lima Castro F; Nogueira FCS; Scalco FB; Pizzatti L; de Aquino Neto FR
    Drug Test Anal; 2017 Nov; 9(11-12):1658-1672. PubMed ID: 29078043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Olympic anti-doping laboratory: the analytical technological road from 2016 Rio De Janeiro to 2021 Tokyo.
    Saad K; Salama S; Horvatovich P; Al Maadheed M; Georgakopoulos C
    Bioanalysis; 2021 Oct; 13(19):1511-1527. PubMed ID: 34617444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detecting - the 2004 Athens Olympic Games.
    Georgakopoulos C
    Drug Test Anal; 2020 May; 12(5):641-646. PubMed ID: 31800156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacy services at the PyeongChang 2018 Olympic and Paralympic Winter Games.
    Stuart M; Kwon YI; Rhie SJ
    Br J Sports Med; 2019 Sep; 53(17):1105-1110. PubMed ID: 30894336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Science and the rules governing anti-doping violations.
    Bowers LD
    Handb Exp Pharmacol; 2010; (195):513-31. PubMed ID: 20020378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medication use in athletes selected for doping control at the Sydney Olympics (2000).
    Corrigan B; Kazlauskas R
    Clin J Sport Med; 2003 Jan; 13(1):33-40. PubMed ID: 12544162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ethical considerations in anti-doping analysis.
    Murray TH
    Bioanalysis; 2012 Jul; 4(13):1537-9. PubMed ID: 22831469
    [No Abstract]   [Full Text] [Related]  

  • 33. [New provisions for prevention and fight against doping].
    Boulu RG
    Ann Pharm Fr; 2002 Sep; 60(5):291-5. PubMed ID: 12378136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sport injuries and illnesses during the first Winter Youth Olympic Games 2012 in Innsbruck, Austria.
    Ruedl G; Schobersberger W; Pocecco E; Blank C; Engebretsen L; Soligard T; Steffen K; Kopp M; Burtscher M
    Br J Sports Med; 2012 Dec; 46(15):1030-7. PubMed ID: 23148325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. National Nutritional Programs for the 2012 London Olympic Games: a systematic approach by three different countries.
    Burke LM; Meyer NL; Pearce J
    Nestle Nutr Inst Workshop Ser; 2013; 76():103-20. PubMed ID: 23899758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is it legal? Prescribing for the athlete.
    Sando BG
    Aust Fam Physician; 1999 Jun; 28(6):549-53. PubMed ID: 10399386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medical services at the first Winter Youth Olympic Games 2012 in Innsbruck/Austria.
    Blank C; Schamasch P; Engebretsen L; Haslinger S; Ruedl G; Fink C; Schobersberger W
    Br J Sports Med; 2012 Dec; 46(15):1048-54. PubMed ID: 23118119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance-enhancing drugs and the Olympics.
    Watson CJ; Stone GL; Overbeek DL; Chiba T; Burns MM
    J Intern Med; 2022 Feb; 291(2):181-196. PubMed ID: 35007384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The toxic torch of the modern Olympic Games.
    Prendergast HM; Bannen T; Erickson TB; Honore KR
    Vet Hum Toxicol; 2003 Mar; 45(2):97-102. PubMed ID: 12678299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A forensic perspective of the AFL investigation into peptides: an antidoping investigation case study.
    Harcourt PR; Marclay F; Clothier B
    Br J Sports Med; 2014 May; 48(10):810-3. PubMed ID: 24642697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.